The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: The Veterans Affairs HDL Intervention Trial (VA-HIT)

E. Shyong Tai, Dorothea Collins, Sander J. Robins, John J. O'Connor, Hanna E. Bloomfield, Jose M. Ordovas, Ernst J. Schaefer, Margaret E. Brousseau

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: The Veterans Affairs HDL Intervention Trial (VA-HIT)'. Together they form a unique fingerprint.

Medicine & Life Sciences